Product Information
DOXYCYCLINE 50 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $4.6998 per EA under NDC 62135062560. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Sep 11, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Chartwell RX LLCNDC
62135062560
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA062505FDA Approved
9/11/1984
TE Code
AB
On Market Since
7/27/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE 50 MG TABLET has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 23.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6998 per EA |
|---|---|
| All-time high | $8.2451 (Mar 15, 2023) |
| All-time low | $2.6730 (Jul 17, 2024) |
| 52-week high | $6.2925 |
| 52-week low | $4.6998 |
| Median price | $5.9949 |
| Average price | $6.1194 |
| Largest weekly change | +65.9% (Jan 18, 2023) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline Hyclate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE 50 MG TABLET, manufactured by Chartwell RX LLC, is $4.6998 per EA (NDC 62135062560), effective Sep 30, 2026.
How has the price of DOXYCYCLINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE 50 MG TABLET has declined 23.6%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE 50 MG TABLET?
Since Sep 21, 2022, the NADAC for DOXYCYCLINE 50 MG TABLET has ranged from a low of $2.6730 (Jul 17, 2024) to a high of $8.2451 (Mar 15, 2023), with a median of $5.9949 per EA.
Are there cheaper alternatives to DOXYCYCLINE 50 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYCYCLINE HYC DR 50 MG TAB, is $1.5694 per EA — about 67% below DOXYCYCLINE 50 MG TABLET.
Who manufactures DOXYCYCLINE 50 MG TABLET?
DOXYCYCLINE 50 MG TABLET (NDC 62135062560) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.